| 06/29/2026 3:30 PM | Marshall Richard Henry (2142265) Reporting TriSalus Life Sciences (1826667) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/29/2026 3:33 PM | Marshall Richard Henry (2142265) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Gordon Gary B. (1811354) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:42 PM | TriSalus Life Sciences (1826667) Issuer Wahlstrom Mats (1459154) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 3:44 PM | First Light Asset Management, LLC (1600004) Filed by TriSalus Life Sciences (1826667) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:03 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2026 7:30 AM | TriSalus Life Sciences (1826667) Subject Utmost Group Plc (2046077) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 3:32 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for TLSIW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/20/2026 3:36 PM | Frankenius Equity AB (1988262) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 8:10 AM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 3:09 PM | MATLIN DAVID J (1251956) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Stevens Jennifer (1982621) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Marshak Richard (1982638) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Cox Bryan F. (1981787) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:25 PM | Devlin Jodi (1992151) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 3:08 PM | TriSalus Life Sciences (1826667) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 3:31 PM | TriSalus Life Sciences (1826667) Filer | Form 424B5 | |
| 02/23/2026 3:08 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | TriSalus Life Sciences (1826667) Issuer Valle William (2018493) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | Gordon Gary B. (1811354) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:08 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 3:15 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 5:50 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/11/2026 5:51 PM | Stansky Michael P (1424204) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 7:59 AM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 6:09 AM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/04/2025 11:15 PM | TriSalus Life Sciences (1826667) Filer | Form EFFECT | |
| 11/25/2025 3:15 PM | Cox Bryan F. (1981787) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:40 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:42 PM | Marshak Richard (1982638) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:43 PM | Stevens Jennifer (1982621) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:55 PM | Szela Mary T (1410289) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 2:56 PM | Devlin Jodi (1992151) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 3:40 PM | TriSalus Life Sciences (1826667) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 11/03/2025 9:00 AM | TriSalus Life Sciences (1826667) Subject Utmost Group Plc (2046077) Filed by | Form SCHEDULE 13G | |
| 10/01/2025 3:28 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Do NOT Buy SpaceX – Do This Instead (Ad) SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors.
Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. Read Tilson's free analysis and find out what to do with your money |
| 08/29/2025 3:18 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/29/2025 3:15 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2025 9:16 AM | TriSalus Life Sciences (1826667) Subject Utmost Group Plc (2046077) Filed by | Form SCHEDULE 13G | |
| 08/15/2025 4:29 PM | Patience David (1970009) Reporting TriSalus Life Sciences (1826667) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2025 3:37 PM | Nantahala Capital Management, LLC (1472322) Filed by TriSalus Life Sciences (1826667) Subject | Form SCHEDULE 13G | |
| 08/04/2025 6:33 AM | Frankenius Equity AB (1988262) Filed by TriSalus Life Sciences (1826667) Subject | Form SCHEDULE 13D/A | |
| 08/01/2025 4:16 PM | TriSalus Life Sciences (1826667) Subject Wahlstrom Mats (1459154) Filed by | Form SCHEDULE 13D/A | |
| 07/24/2025 4:30 PM | TriSalus Life Sciences (1826667) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/22/2025 11:15 PM | TriSalus Life Sciences (1826667) Filer | Form EFFECT | |
| 07/11/2025 4:00 PM | TriSalus Life Sciences (1826667) Filer | Form S-4/A | |